Clinical Trials Directory

Trials / Unknown

UnknownNCT04259112

Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients

Effect of Pneumoperitoneum Pressure and the Extent of Neuromuscular Block on Renal Function in Patients With Diabetes Undergoing Laparoscopic Pelvic Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
648 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Deep neuromuscular block is defined as post tetanic count (PTC) 1-2, and low neuromuscular block is defined as train-of-four (TOF) twitch 1-2. The outcomes will be indicators for acute kidney injury and surgical condition.

Detailed description

In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection under general anesthesia. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Neuromuscular block will be induced by rocuronium bolus and maintained by a continuous infusion of rocuronium. Deep neuromuscular block is defined as PTC 1-2, and low neuromuscular block is defined as train-of-four TOF twitch 1-2. The primary outcome will be serum Cystatin C level, and the secondary outcomes will be serum creatine level, urinary sediment, intraoperative urine output, duration of surgery, surgical space condition and occurrence bucking and body movement.

Conditions

Interventions

TypeNameDescription
PROCEDUREhigh pressureHigh-pressure pneumoperitoneum is defined as intra-abdominal pressure 12-15 mmHg.
DRUGdeep neuromuscular blockDeep neuromuscular block is defined as PTC 1-2.
PROCEDURElow pressureLow-pressure pneumoperitoneum is defined as intra-abdominal pressure 7-10 mmHg.
DRUGmoderate neuromuscular blockModerate neuromuscular block is defined as TOF twitch 1-2.

Timeline

Start date
2020-10-01
Primary completion
2023-10-01
Completion
2023-12-01
First posted
2020-02-06
Last updated
2020-10-06

Source: ClinicalTrials.gov record NCT04259112. Inclusion in this directory is not an endorsement.